Clinical Trial Update: Phase I/II Hypofractionated Radiotherapy for Prostate Cancer [Phase 1, Phase 2]

View source ↗

Summary

Phase I/II trial investigating hypofractionated radiotherapy for prostate cancer completed with results posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Prostate Cancer

Snippet

Sponsor: University of Wisconsin, Madison | Conditions: Prostate Cancer | Phase 1, Phase 2 | Status: COMPLETED | Results posted: 2019-10-22